APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy.
Ontology highlight
ABSTRACT: Tumor-associated neo-antigens are mutated peptides that allow the immune system to recognize the affected cell as foreign. Cells carrying excessive mutation load often develop mechanisms of tolerance. PD-L1/PD-1 checkpoint immunotherapy is a highly promising approach to overcome these protective signals and induce tumor shrinkage. Yet, the nature of the neo-antigens driving those beneficial responses remains unclear. Here, we show that APOBEC-related mutagenesis - a mechanism at the crossroads between anti-viral immunity and endogenous nucleic acid editing - increases neo-peptide hydrophobicity (a feature of immunogenicity), as demonstrated by in silico computation and in the TCGA pan-cancer cohort, where APOBEC-related mutagenesis was also strongly associated with immune marker exp
SUBMITTER: Boichard A
PROVIDER: S-EPMC6350681 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA